25 May 2013
Keywords: fda, approvable, letters, dalbavancin, luvox, cr, bazedoxifene
Article | 07 January 2008
The US Food and Drug Administration has issued an "approvable" letter for dalbavancin HCl, Pfizer's once-weekly two-dose antibiotic under
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2008
24 May 2013
© 2013 thepharmaletter.com